References
155
Hevener KE, Cao S, Zhu T et al. (2013) Special challenges to the rational design of antibacterial
agents. In: Desai MC (ed-in-chief) Annual reports in medicinal chemistry, vol 48. Academic
Press, San Diego, pp 283–298
Hibbard HAJ, Reynolds MM (2019a) Fluorescent nitric oxide donor for the detection and killing
of Pseudomonas aeruginosa. J Mater Chem B 7(12):2009–2018
Hibbard HAJ, Reynolds MM (2019b) Synthesis of novel nitroreductase enzyme-activated nitric
oxide prodrugs to site-specifically kill bacteria. Bioorg Chem 93:103318
Ho TT, Tran QT, Chai CL (2018) The polypharmacology of natural products. Future Med Chem
10 (11):1361–1368
Hou Y, Yang M, Jiang H et al. (2019) Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs)
Escherichia coli. FEMS Microbiol Lett 366 (3): fnz026
Iscla I, Blount P (2012) Sensing and responding to membrane tension: The bacterial MscL channel
as a model system. Biophys J 103 (2):169–174
Iscla I, Wray R, Blount P et al. (2015) A new antibiotic with potent activity targets MscL. J Antibiot
68 (7):453–462
Jain R, Chen D, White RJ et al. (2005) Bacterial peptide deformylase inhibitors: a new class of
antibacterial agents. Curr Med Chem 12 (14):1607–1621
Jansen R, Gerth K, Steinmetz H et al. (2011) Elansolid A3, a unique p-quinone methide antibiotic
from Chitinophaga sancti. Chem Eur J 17 (28):7739–7744
Ji X, Pan Z, Yu B et al. (2019) Click and release: bioorthogonal approaches to “on-demand”
activation of prodrugs. Chem Soc Rev 48 (4):1077–1094
Ji X, Wang B (2018) Strategies toward organic carbon monoxide prodrugs. Acc Chem Res 51
(6):1377–1385
Jubeh B, Breijyeh Z, Karaman R (2020) Antibacterial prodrugs to overcome bacterial resistance.
Molecules 25 (7):1543
Klaue K, Garmshausen Y, Hecht S (2018) Taking photochromism beyond visible: direct one-photon
NIR photoswitches operating in the biological window. Angew Chem Int Ed 57 (5):1414–1417
Kutty SK, Barraud N, Ho KKK et al. (2015) Hybrids of acylated homoserine lactone and nitric
oxide donors as inhibitors of quorum sensing and virulence factors in Pseudomonas aeruginosa.
Org Biomol Chem 13 (38):9850–9861
Kutty SK, Barraud N, Pham A et al. (2013) Design, synthesis, and evaluation of fimbrolide–nitric
oxide donor hybrids as antimicrobial agents. J Med Chem 56 (23):9517–9529
Leach KL, Swaney SM, Colca JR et al. (2007) The site of action of oxazolidinone antibiotics in
living bacteria and in human mitochondria. Mol Cell 26 (3):393–402
Lee M-R, Baek K-H, Jin HJ et al. (2004) Targeted enzyme-responsive drug carriers: Studies on the
delivery of a combination of drugs. Angew Chem Int Ed 43 (13):1675–1678
Lee SK, Choi KH, Lee SJ et al. (2010) Peptide deformylase inhibitors with retro-amide scaffold:
Synthesis and structure–activity relationships. Bioorg Med Chem Lett 20 (15):4317–4319
Levine SR, Beatty KE (2019) Investigating β-lactam drug targets in Mycobacterium tuberculosis
using chemical probes. bioRxiv:2019.2012.2019.881631
Li G (2018) First oral antibiotic booster for four decades could tackle drug resistance. Chem World
15 (12):32
Li J, Kong H, Zhu C et al. (2020) Photo-controllable bioorthogonal chemistry for spatiotemporal
control of bio-targets in living systems. Chem Sci 11 (13):3390–3396
Li Y-H, Li Y, Yang P et al. (2010) Design, synthesis, and cholesterol-lowering efficacy for prodrugs
of berberrubine. Bioorg Med Chem 18 (17):6422–6428
Liao X, Li J, Suo Y et al. (2018) Multiple action sites of ultrasound on Escherichia coli and
Staphylococcus aureus. Food Sci Hum Well 7 (1):102–109
Ling K, Men F, Wang W-C et al. (2018) Carbon monoxide and its controlled release: Therapeutic
application, detection, and development of carbon monoxide releasing molecules (CORMs). J
Med Chem 61 (7):2611–2635
155
Hevener KE, Cao S, Zhu T et al. (2013) Special challenges to the rational design of antibacterial
agents. In: Desai MC (ed-in-chief) Annual reports in medicinal chemistry, vol 48. Academic
Press, San Diego, pp 283–298
Hibbard HAJ, Reynolds MM (2019a) Fluorescent nitric oxide donor for the detection and killing
of Pseudomonas aeruginosa. J Mater Chem B 7(12):2009–2018
Hibbard HAJ, Reynolds MM (2019b) Synthesis of novel nitroreductase enzyme-activated nitric
oxide prodrugs to site-specifically kill bacteria. Bioorg Chem 93:103318
Ho TT, Tran QT, Chai CL (2018) The polypharmacology of natural products. Future Med Chem
10 (11):1361–1368
Hou Y, Yang M, Jiang H et al. (2019) Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs)
Escherichia coli. FEMS Microbiol Lett 366 (3): fnz026
Iscla I, Blount P (2012) Sensing and responding to membrane tension: The bacterial MscL channel
as a model system. Biophys J 103 (2):169–174
Iscla I, Wray R, Blount P et al. (2015) A new antibiotic with potent activity targets MscL. J Antibiot
68 (7):453–462
Jain R, Chen D, White RJ et al. (2005) Bacterial peptide deformylase inhibitors: a new class of
antibacterial agents. Curr Med Chem 12 (14):1607–1621
Jansen R, Gerth K, Steinmetz H et al. (2011) Elansolid A3, a unique p-quinone methide antibiotic
from Chitinophaga sancti. Chem Eur J 17 (28):7739–7744
Ji X, Pan Z, Yu B et al. (2019) Click and release: bioorthogonal approaches to “on-demand”
activation of prodrugs. Chem Soc Rev 48 (4):1077–1094
Ji X, Wang B (2018) Strategies toward organic carbon monoxide prodrugs. Acc Chem Res 51
(6):1377–1385
Jubeh B, Breijyeh Z, Karaman R (2020) Antibacterial prodrugs to overcome bacterial resistance.
Molecules 25 (7):1543
Klaue K, Garmshausen Y, Hecht S (2018) Taking photochromism beyond visible: direct one-photon
NIR photoswitches operating in the biological window. Angew Chem Int Ed 57 (5):1414–1417
Kutty SK, Barraud N, Ho KKK et al. (2015) Hybrids of acylated homoserine lactone and nitric
oxide donors as inhibitors of quorum sensing and virulence factors in Pseudomonas aeruginosa.
Org Biomol Chem 13 (38):9850–9861
Kutty SK, Barraud N, Pham A et al. (2013) Design, synthesis, and evaluation of fimbrolide–nitric
oxide donor hybrids as antimicrobial agents. J Med Chem 56 (23):9517–9529
Leach KL, Swaney SM, Colca JR et al. (2007) The site of action of oxazolidinone antibiotics in
living bacteria and in human mitochondria. Mol Cell 26 (3):393–402
Lee M-R, Baek K-H, Jin HJ et al. (2004) Targeted enzyme-responsive drug carriers: Studies on the
delivery of a combination of drugs. Angew Chem Int Ed 43 (13):1675–1678
Lee SK, Choi KH, Lee SJ et al. (2010) Peptide deformylase inhibitors with retro-amide scaffold:
Synthesis and structure–activity relationships. Bioorg Med Chem Lett 20 (15):4317–4319
Levine SR, Beatty KE (2019) Investigating β-lactam drug targets in Mycobacterium tuberculosis
using chemical probes. bioRxiv:2019.2012.2019.881631
Li G (2018) First oral antibiotic booster for four decades could tackle drug resistance. Chem World
15 (12):32
Li J, Kong H, Zhu C et al. (2020) Photo-controllable bioorthogonal chemistry for spatiotemporal
control of bio-targets in living systems. Chem Sci 11 (13):3390–3396
Li Y-H, Li Y, Yang P et al. (2010) Design, synthesis, and cholesterol-lowering efficacy for prodrugs
of berberrubine. Bioorg Med Chem 18 (17):6422–6428
Liao X, Li J, Suo Y et al. (2018) Multiple action sites of ultrasound on Escherichia coli and
Staphylococcus aureus. Food Sci Hum Well 7 (1):102–109
Ling K, Men F, Wang W-C et al. (2018) Carbon monoxide and its controlled release: Therapeutic
application, detection, and development of carbon monoxide releasing molecules (CORMs). J
Med Chem 61 (7):2611–2635